Literature DB >> 25581127

Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site.

Rajendra P Tanpure1, Bin Ren, Thomas S Peat, Laurent F Bornaghi, Daniela Vullo, Claudiu T Supuran, Sally-Ann Poulsen.   

Abstract

We present a new approach to carbonic anhydrase II (CA II) inhibitor design that enables close interrogation of the regions of the CA active site where there is the greatest variability in amino acid residues among the different CA isozymes. By appending dual tail groups onto the par excellence CA inhibitor acetazolamide, compounds that may interact with the distinct hydrophobic and hydrophilic halves of the CA II active site were prepared. The dual-tail combinations selected included (i) two hydrophobic moieties, (ii) two hydrophilic moieties, and (iii) one hydrophobic and one hydrophilic moiety. The CA enzyme inhibition profile as well as the protein X-ray crystal structure of compound 3, comprising one hydrophobic and one hydrophilic tail moiety, in complex with CA II is described. This novel dual-tail approach has provided an enhanced opportunity to more fully exploit interactions with the CA active site by enabling these molecules to interact with the distinct halves of the active site. In addition to the dual-tail compounds, a corresponding set of single-tail derivatives was synthesized, enabling a comparative analysis of the single-tail versus dual-tail compound CA inhibition profile.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25581127     DOI: 10.1021/jm501798g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

Review 1.  Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer.

Authors:  Kathryn F Tonissen; Sally-Ann Poulsen
Journal:  Cancer Drug Resist       Date:  2021-06-19

2.  An efficient strategy to enhance binding affinity and specificity of a known isozyme inhibitor.

Authors:  Joo-Eun Jee; Jaehong Lim; Yong Siang Ong; Jessica Oon; Liqian Gao; Hak Soo Choi; Su Seong Lee
Journal:  Org Biomol Chem       Date:  2016-07-12       Impact factor: 3.876

3.  Synthesis of Novel Saccharin Derivatives.

Authors:  Gregory M Rankin; Sally-Ann Poulsen
Journal:  Molecules       Date:  2017-03-23       Impact factor: 4.411

4.  Benzylaminoethyureido-Tailed Benzenesulfonamides: Design, Synthesis, Kinetic and X-ray Investigations on Human Carbonic Anhydrases.

Authors:  Majid Ali; Murat Bozdag; Umar Farooq; Andrea Angeli; Fabrizio Carta; Paola Berto; Giuseppe Zanotti; Claudiu T Supuran
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

5.  PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX.

Authors:  Utpal K Mondal; Kate Doroba; Ahmed M Shabana; Rachel Adelberg; Md Raqibul Alam; Claudiu T Supuran; Marc A Ilies
Journal:  Int J Mol Sci       Date:  2021-01-23       Impact factor: 5.923

Review 6.  Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.

Authors:  Alessio Nocentini; Andrea Angeli; Fabrizio Carta; Jean-Yves Winum; Raivis Zalubovskis; Simone Carradori; Clemente Capasso; William A Donald; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

7.  An overview of carbohydrate-based carbonic anhydrase inhibitors.

Authors:  Doretta Cuffaro; Elisa Nuti; Armando Rossello
Journal:  J Enzyme Inhib Med Chem       Date:  2020-10-20       Impact factor: 5.051

Review 8.  Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors.

Authors:  Claudiu T Supuran
Journal:  J Exp Pharmacol       Date:  2020-12-15

9.  Synthesis and Biological Evaluation of Imidazo[2 ,1-b]Thiazole based Sulfonyl Piperazines as Novel Carbonic Anhydrase II Inhibitors.

Authors:  Kesari Lakshmi Manasa; Sravya Pujitha; Aaftaab Sethi; Arifuddin Mohammed; Mallika Alvala; Andrea Angeli; Claudiu T Supuran
Journal:  Metabolites       Date:  2020-03-31

10.  Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action.

Authors:  Alessandro Bonardi; Alessio Nocentini; Silvia Bua; Jacob Combs; Carrie Lomelino; Jacob Andring; Laura Lucarini; Silvia Sgambellone; Emanuela Masini; Robert McKenna; Paola Gratteri; Claudiu T Supuran
Journal:  J Med Chem       Date:  2020-06-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.